living with MS

Anne Rosales is a mother of three grown children, grandmother, and community volunteer. She was diagnosed with multiple sclerosis (MS) in her mid-50s. She holds a Master of Business Administration from Stanford University and is a certified aging-in-place specialist. Rosales blogs about midlife health and wellness at…

To mark World MS Day, which takes place annually on May 30, the International Progressive MS Alliance is introducing a research program to help drive early innovations in care programs for those with progressive forms of multiple sclerosis (MS). Specifically, the program seeks to identify solutions to…

I don’t know why I find it so impossible to sit still. I feel like every moment I’m not engaged in some creative pursuit, I’m somehow missing out. Or worse, I’m squandering what poet Mary Oliver calls my “one wild and precious life.” Multiple sclerosis (MS) has done…

Welcome to “MS News Notes,” a Monday morning column where I comment on multiple sclerosis (MS) news stories that caught my eye last week. Here’s a look at what’s been happening: Early stem cell transplants I’ve read the headline “Stem cell therapy may do most good when given…

An updated snapshot of multiple sclerosis (MS) in the U.S. — provided by new population estimates from a study of insurance data — shows a greater prevalence of MS among white and Black people compared with other racial and ethnic groups. But overall, the neurodegenerative disorder has become more…

Memorial Day, the unofficial start of summer vacation in the U.S., is fast approaching. It’s almost time for some summer beach fun — if we can get there. Beaches can be difficult, if not impossible, to access for many people with multiple sclerosis (MS). But times seem to be…

I’ve always liked the phrase “go with what you know.” I suppose I understood it to mean “stick to what you’re good at” or simply, “stay in your lane.” Recently, though, I stumbled on a slightly different meaning that I like even better. “Use knowledge you already have as a…

People with multiple sclerosis (MS) who have never received treatment with a disease-modifying therapy tend to have better long-term outcomes after stem cell transplant, according to a recent report from a center in Mexico. The findings suggest that stem cell therapy may be most beneficial when given…

Guest columnist Lori Lebson completed her PhD in neuroimmunology at the University of South Florida. After completing her doctorate, she continued her education as a National Multiple Sclerosis Society Neuroimmunology Postdoctoral Fellow at Johns Hopkins. Lebson has more than 10 years of pharmaceutical experience and serves as the head of…

The artificial intelligence (AI)-driven platform BeCare Link has introduced a mobile application to help multiple sclerosis (MS) patients be more active in their care and ensure clinicians have the data to treat them. BeCare MS Link, the platform’s first subspecialty product, is touted as the most comprehensive…

A recent post on the MS-Selfie blog asks and answers this question: What is the “greatest unmet need” concerning multiple sclerosis (MS)? Professor Gavin Giovannoni, the London-based neurologist who writes that blog, lists five unmet needs, many of which I agree with. But those needs are from the viewpoint…

The rate of multiple sclerosis (MS) diagnoses have remained relatively constant for almost 20 years in the U.K., according to a population-based study involving more than 22 million people. Most MS diagnoses occurred during middle age, with women being more likely than men to receive a…

People with multiple sclerosis and a history of chronic opioid use are nearly 200 times more likely to use prescription opioids persistently, according to a study involving nearly 15,000 U.S. military veterans living with the neurodegenerative condition. A history of pain, paralysis, post-traumatic stress disorder, or living in a…

The online platform DrTalks is offering a free virtual summit this summer aimed at helping multiple sclerosis (MS) patients and their caregivers better manage daily life with the progressive neurodegenerative condition. The event is slated for July 5-11, and has more than four dozen speakers lined up. Talks…

A four-month home-based aerobic walking program was feasible and may help improve cognitive function for multiple sclerosis (MS) patients, according to data from a recent pilot study funded by the Kessler Foundation. Findings from this small study support the design of a randomized, controlled clinical trial to evaluate…

The Multiple Sclerosis Association of America (MSAA) is collaborating with Novartis and the Chronic Health Improvement Research Program (CHIRP) at Dartmouth Health to establish a multicenter learning health network for providers to drive better outcomes for multiple sclerosis (MS) patients. Called the Multiple Sclerosis Implementation Network…

Everyone’s multiple sclerosis (MS) is unique to them. The different disease types, lesion loads, and lesion locations are a few reasons why our symptoms are so variable. We with MS all live in the same neighborhood, just in different houses. If there were such a thing as…

Jonathan Allenger, diagnosed with multiple sclerosis (MS) a decade ago, is planning to bike more than 6,000 kilometers (3,700 miles) across Canada to raise awareness and CA$1 million for MS research and patient support services. Proceeds from the journey — set to begin on May 7 and conclude by…

The recently approved CD20 inhibitor Briumvi (ublituximab-xiiy) has received a permanent insurance reimbursement code that will simplify claims submissions and documentation processes for adults in the U.S. with relapsing forms of multiple sclerosis who are prescribed it. Issued by the U.S. Centers for Medicare and Medicaid Services, the…

Rehabilitation therapy that utilizes virtual reality can help to improve balance and reduce the fear of falling for people with multiple sclerosis (MS), a new analysis shows. “Our findings provide support to the use of [virtual reality-based therapy] to recover balance in neurological diseases such as MS,” researchers wrote.

Ceilings. Oh yeah, I’ve become quite the expert on ceilings. If you spend much of your life prostrate, it’s hard not to. The very first column I wrote for Multiple Sclerosis News Today opened with this very topic. As it was an unsolicited spec piece, I was pleasantly…

Note: This column describes the author’s own experiences with Ocrevus (ocrelizumab). Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. Tomorrow morning, I’ll have my 13th infusion of Ocrevus (ocrelizumab). I’ve been approved for the fast infusion rate, so…

I don’t really like problems. And I don’t think I’m alone in this. No one I know wakes up hoping a seemingly insurmountable obstacle or painful trial is flung smack in the middle of their path. If it were up to me, I’d rather wake up to perfect hair, hit…

COVID-19 had finally left me. Its only trace was a pair of slimy hands. For a month, I requested a towel in bed to wipe them dry. My wife, Jane, told me my hands were fine; my phone’s screen, however, didn’t agree. As my companion in the hospital…

I’m pretty good at doing what I’m told. You probably think that’s because I was in the Army for 22 years. You might even think it’s because of all the medical authority figures that have come with nine years of multiple sclerosis (MS). Of course, they both factor in,…